NEW YORK--(BUSINESS WIRE)--VanEck is today marking the fifth anniversary of the VanEck Vectors® Israel ETF (NYSE Arca: ISRA®), a fund designed to offer broad and diversified exposure to Israel’s globally oriented economy.
“We launched ISRA to provide a comprehensive solution for investors who are attracted to Israel’s compelling growth story,” said Ed Lopez, Head of ETF Product at VanEck. “The underlying index allows the ETF to provide the broadest exposure to Israel’s economy from a U.S.-listed ETF by including Israeli equities trading globally. It also shares a similar philosophy to VanEck’s other country funds by including companies with meaningful exposure to Israel in a well-diversified way.”
ISRA tracks the price and yield performance of the BlueStar Israel Global Index® - BIGI® (Index ticker: BLSNTR). As of May 31, 2018, the top three sectors in the index by weighting were Information Technology (35.5%), Healthcare (22.3%), and Financials (17.4%). Also represented in the index were the real estate, energy, materials, and industrials sectors, as well as a number of other key parts of the Israeli economy. The index is the broadest benchmark of Israeli equities trading worldwide, and includes 134 stocks listed on seven exchanges, including the Tel Aviv Stock Exchange, Nasdaq, the NYSE, Australia’s ASX, and the London, Hong Kong, and Singapore exchanges.
“Israel is home to some of the most innovative companies in the world, yet its dynamic economy has often been difficult for investors to access in a meaningful way,” said Steven Schoenfeld, founder and Chief Investment Officer of BlueStar Indexes®. “With ISRA, our partners at VanEck constructed a thoughtfully designed ETF that provides investors with a diversified, liquid, and transparent means of adding exposure to the Israeli growth story—a story which has remained compelling in the face of growing global uncertainty.”
VanEck and BlueStar Indexes are especially proud that ISRA has historically been the investment vehicle of choice for major endowments and foundations to implement their first dedicated allocations to Israeli equities, a trend that is accelerating. Furthermore, a wide range of financial advisors, wealth managers, and sophisticated individual investors have gained efficient exposure to Israel via the VanEck Vectors Israel ETF.
VanEck has a history of looking beyond the financial markets to identify trends that are likely to create impactful investment opportunities. We were one of the first U.S. asset managers to offer investors access to international markets. This set the tone for the firm’s drive to identify asset classes and trends – including gold investing in 1968, emerging markets in 1993, and exchange traded funds in 2006 – that subsequently shaped the investment management industry.
Today, VanEck offers active and passive strategies with compelling exposures supported by well-designed investment processes. As of May 31, 2018, VanEck managed approximately $45.5 billion in assets, including mutual funds, ETFs, and institutional accounts. The firm’s capabilities range from core investment opportunities to more specialized exposures to enhance portfolio diversification. Our actively managed strategies are fueled by in-depth, bottom-up research and security selection from portfolio managers with direct experience in the sectors and regions in which they invest. Investability, liquidity, diversity, and transparency are key to the experienced decision-making around market and index selection underlying VanEck’s passive strategies.
Since our founding in 1955, putting our clients’ interests first, in all market environments, has been at the heart of the firm’s mission.
An investment in the VanEck Vectors Israel ETF (ISRA) may be subject to risks which include, among others, investing in Israeli issuers, foreign securities, foreign currency, depositary receipts, financial services sector, health care sector, information technology sector, small-, medium- and micro-capitalization companies, equity securities, market, operational, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount risk and liquidity of fund shares, non-diversified and concentration risks, all of which may adversely affect the Fund. Foreign investments are subject to risks, which include changes in economic and political conditions, foreign currency fluctuations, changes in foreign regulations, and changes in currency exchange rates which may negatively impact the Fund's return. Small-, medium- and micro-capitalization companies may be subject to elevated risks. The Fund's assets may be concentrated in a particular sector and may be subject to more risk than investments in a diverse group of sectors.
The BlueStar Israel Global Index® is the exclusive property and a trademark of BlueStar Global Investors LLC and has been licensed for use for certain purposes by Van Eck Associates Corporation for VanEck Vectors Israel ETF (the "Fund") based on the BlueStar Israel Global Index®. The Fund is not sponsored, endorsed, sold or promoted by BlueStar Global Investors LLC, and BlueStar Global Investors LLC makes no representation regarding the advisability of trading in the Fund.
Indices are unmanaged and are not securities in which an investment can be made.
Diversification does not assure a profit nor protect against loss in a declining market.
Fund shares are not individually redeemable and will be issued and redeemed at their net asset value (NAV) only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Shares may trade at a premium or discount to their NAV in the secondary market. You will incur brokerage expenses when trading Fund shares in the secondary market. Past performance is no guarantee of future results.
Investing involves substantial risk and high volatility, including possible loss of principal. Bonds and bond funds will decrease in value as interest rates rise. An investor should consider the investment objective, risks, charges and expenses of the Fund carefully before investing. To obtain a prospectus and summary prospectus, which contains this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.
Van Eck Securities Corporation, Distributor
666 Third Avenue
New York, NY 10017